Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: Immuneering Corporation, 2 years.
Immuneering Corporation
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Immuneering Corporation June 13, 2025100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 15, 2026 | Immuneering Corporation | Open-market purchase | +21,645 | $4.67 | $101,082 |
| Jun 27, 2025 | Immuneering Corporation | Open-market purchase | +9,500 | $3.66 | $34,770 |
| Jun 17, 2025 | Immuneering Corporation | Open-market purchase | +40,485 | $2.21 | $89,472 |
| Mar 22, 2024 | Immuneering Corporation | Open-market purchase | +2,900 | $2.55 | $7,395 |
Questions about Thomas J. Schall
What boards is Thomas J. Schall on?
Thomas J. Schall sits on the board of Immuneering Corporation.
How long has Thomas J. Schall served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.